Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sunday, December 21, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Biotech
Ventus Therapeutics announces first patient dosed in Phase 2 trial of VENT-03 for lupus
Life Sciences Times
-
December 10, 2025
0
People on the Move
INBRAIN Neuroelectronics Names Scott Huennekens Chairman of the Board
Life Sciences Times
-
December 9, 2025
0
Venture Capital
Montagu and Kohlberg Agree to Acquire Teleflex Medical OEM for $1.5 Billion
Life Sciences Times
-
December 9, 2025
0
Biotech
Avant Technologies, Austrianova Advance α-Klotho Cell Therapy Following Mayo Clinic Findings on Cardiovascular Risk
Life Sciences Times
-
December 9, 2025
0
Pharma
FDA Accepts Tris Pharma’s NDA for Once-Nightly, Low-Sodium Oxybate for Narcolepsy and Idiopathic Hypersomnia
Life Sciences Times
-
December 9, 2025
0
Biotech
Aleta Biotherapeutics and Cancer Research UK Report Early Phase I/II Results for ALETA-001 in B-Cell Malignancies
Life Sciences Times
-
December 9, 2025
0
Life Sciences
Study Links Tumor Metabolism to Drug Binding Behavior in Live Cancer Cells
Life Sciences Times
-
December 9, 2025
0
Technology
athenahealth to Add Microsoft Dragon Copilot to Ambient Notes Tool in 2026
Life Sciences Times
-
December 9, 2025
0
Pharma
Delphia Therapeutics Adds Cancer Expert Steve Kelsey, M.D., to Board of Directors
Life Sciences Times
-
December 9, 2025
0
Venture Capital
Mirum Pharmaceuticals to Acquire Bluejay Therapeutics, Expanding Rare Disease Portfolio
Life Sciences Times
-
December 8, 2025
0
1
...
5
6
7
...
773
Page 6 of 773
Most Popular
Manifold Raises $18 Million Series B to Expand Vertical AI Platform for Life Sciences
December 19, 2025
PureTech Appoints Robert Lyne as Chief Executive Officer
December 19, 2025
Orum Therapeutics Raises Approximately $100 Million to Advance Degrader Antibody Conjugate Programs
December 19, 2025
Syremis Therapeutics Launches With $165 Million Series A to Advance New Treatments for Mental Health Disorders
December 19, 2025
Load more
Recent Comments
Recent Comments